IP Library Granted Patent US 7,856,321
Granted Patent B2
US 7,856,321 · App. 11/304,209 · Granted Dec 21, 2010

Modeling biological effects of molecules using molecular property models

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,856,321
App. No.
11/304,209
Granted
Dec 21, 2010
Kind
B2
Abstract

Method, apparatus, and article of manufacture for modeling the biological effects of a molecule are disclosed. A machine learning application may be configured to process a set of training examples regarding a biological property of interest. Once trained, the machine learning application may be configured to generate a prediction regarding a property of interest for a test molecule. Embodiments of the invention provide a meta-model configured to generate a biological effect prediction for a molecule based on the predictions generated for the test molecule by a plurality of molecular property models.

Claims (38)

1. A method for determining whether one or more test molecules has a biological effect selected from the group consisting of an antibacterial effect, an antiviral effect and an anticancer effect, comprising:

training on a suitably programmed computer more than three different molecular property models using at least one of a first set of training data, wherein each trained molecular property model is configured to generate a molecular property model prediction regarding a property of interest of the one or more test molecules, wherein said molecular property models are used in determining different properties of interest distinct from the biological effect;

using machine learning techniques to train on a suitably programmed computer system a meta-model to predict the biological effect using a second set of training data, wherein a representation of at least one molecule in the second set of training data includes predictions for the one or more test molecules generated by said molecular property models; and

establishing a prediction, using the computer implemented trained meta-model, that one or more test molecules has the biological effect based on the molecular property model predictions.

2. The method of claim 1 , after the more than three molecular property models are trained, comprising:

selecting the test molecule;

generating a representation of the test molecule for use by the plurality of molecular property models;

providing the representation of the test molecule to the plurality of molecular property models to obtain the molecular property model predictions.

3. The method of claim 2 , after the meta-model is trained, comprising:

providing the molecular property model predictions obtained from each of the molecular property models to the meta-model; and

generating a biological effect prediction for the test molecule.

4. The method of claim 1 , wherein the first set of training data comprises a set of individual training examples, and wherein each example represents at least one molecule, and wherein each training example comprises a representation of the at least one molecule and a value for the property of interest modeled by at least one respective molecular property model.

5. The method of claim 4 , wherein training the more than three molecular property models, comprises:

generating a form of each training example for use by a machine learning algorithm; and

performing the machine learning algorithm using the set of individual training examples to generate a trained one of the plurality of molecular property models.

6. A method for determining whether one or more test molecules has a biological effect selected from the group consisting of an antibacterial effect, an antiviral effect and an anticancer effect, comprising:

training on a suitably programmed computer more than three different single target activity models using at least one of a first set of training data, wherein each trained single target activity model is configured to generate a molecular property model prediction regarding a property of interest of the one or more test molecules, wherein said single target activity models are used in determining different properties of interest distinct from the biological effect;

using machine learning techniques to train on a suitably programmed computer the meta-model to predict the biological effect using a second set of training data, wherein a representation of at least one molecule in the second set of training data includes predictions for the one or more test molecules generated by said single target activity models; and

establishing a prediction, using the computer implemented trained meta-model, that one or more of the test molecules has the biological effect based on the molecular property model predictions.

7. The method of claim 6 , after the plurality of single target activity models are trained, comprising:

selecting the test molecule;

generating a representation of the test molecule for use by the more than three single target activity models;

providing the representation of the test molecule to the plurality of single target activity models to obtain the single target activity model predictions.

8. The method of claim 7 , after the meta-model is trained, comprising:

providing the single target activity model predictions obtained from each of the single target activity models to the meta-model; and

generating a biological effect prediction for the test molecule.

9. The method of claim 6 , wherein the first set of training data comprises a set of individual training examples, and wherein each example represents at least one molecule, and wherein each training example comprises a representation of the at least one molecule and a value for the property of interest modeled by each respective single target activity model.

10. The method of claim 9 , wherein training a plurality of single target activity models, comprises:

generating a form of each training example for use by a machine learning algorithm; and

performing the machine learning algorithm using the set of individual training examples to generate a trained one of the more than three single target activity models.

11. The method of claim 1 , wherein one or more of said molecular property models is a single target activity model.

12. The method of claim 11 , wherein the single target activity model is configured to predict activity against a non-human target and the meta-model is trained to predict a human biological effect.

13. The method of claim 11 , wherein the single target activity model is configured to predict activity against a human target and the meta-model is trained to predict a non-human biological effect.

14. The method of claim 1 , wherein one or more of said molecular property models is known not to be associated with the biological effect.

15. The method of claim 1 , further comprising:

performing a laboratory experiment for the biological effect on the one or more test molecules predicted to have the biological effect.

16. The method of claim 6 , further comprising:

performing a laboratory experiment for the biological effect on the one or more test molecules predicted to have the biological effect.

Assignments (9)
RELEASE OF SECURITY INTEREST Recorded May 13, 2024
From: SILICON VALLEY BANK, A DIVISION OF FIRST-CITIZENS BANK & TRUST COMPANY
To: VALO HEALTH, INC.; VALO HEALTH, LLC
Reel/Frame 067394/0291 →
SECURITY INTEREST Recorded Jul 6, 2023
From: VALO HEALTH, LLC; VALO HEALTH, INC.
To: FIRST-CITIZENS BANK & TRUST COMPANY, AS AGENT
Reel/Frame 064207/0957 →
CHANGE OF NAME Recorded Sep 16, 2020
From: INTEGRAL HEALTH, INC.
To: VALO HEALTH, INC.
Reel/Frame 053787/0514 →
SECURITY INTEREST Recorded Jun 15, 2020
From: INTEGRAL HEALTH, INC.
To: SILICON VALLEY BANK
Reel/Frame 052943/0660 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 12, 2020
From: NUMERATE, INC.
To: INTEGRAL HEALTH, INC.
Reel/Frame 052932/0861 →
RELEASE OF SECURITY INTEREST Recorded Sep 18, 2019
From: LEADER VENTURES, LLC
To: NUMERATE, INC.
Reel/Frame 050417/0740 →
SECURITY AGREEMENT Recorded Feb 11, 2013
From: NUMERATE, INC.
To: LEADER VENTURES, LLC, AS AGENT
Reel/Frame 029793/0056 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 2, 2007
From: PHARMIX CORPORATION
To: NUMERATE, INC.
Reel/Frame 020063/0499 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 29, 2006
From: LANZA, GUIDO; DUFFY, NIGEL P.; BOARDMAN, PAUL
To: PHARMIX CORPORATION
Reel/Frame 017395/0376 →